비교리스트

 카트 문의
시장보고서
상품코드
1297824

세계의 등온 핵산 증폭 기술 시장(2023-2030년)

Global Isothermal Nucleic Acid Amplification Technology Market - 2023-2030
발행일: | 리서치사: DataM Intelligence | 페이지 정보: 영문 195 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

시장 개요

세계 등온 핵산 증폭 기술 시장은 2022년 33억 달러에 달할 것으로 예상되며, 2030년에는 75억 달러에 달할 것으로 예상됩니다. 등온 핵산 증폭 기술 시장은 2023-2030년 예측 기간 동안 11.1%의 CAGR을 보일 것으로 예상됩니다.

등온 핵산 증폭은 일정한 온도에서 빠르고 효과적으로 핵산 계열을 수집하는 기술입니다. 핵산 증폭 기술은 분자 생물학 및 재조합 DNA 접근법에서 채택되고 있습니다. 이러한 방법은 짧은 수의 핵산을 식별하고 조사할 때 가장 많이 사용되는 방법입니다.

시장 역학

세계 감염병 확산이 예측 기간 동안 세계 등온 핵산 증폭 기술 시장을 견인

감염병의 세계 유병률 증가는 예측 기간 동안 세계 등온 핵산 증폭 기술(INAAT) 시장의 성장을 주도하고 있습니다. 예를 들어, 세계보건기구(WHO)는 2022년 10월 24일부터 2022년 11월 23일 사이에 5,000명 이상의 새로운 원숭이 수두 환자를 등록했습니다. 또한, 2021년 말에는 미국 대통령 에이즈 대책 긴급 계획의 HIV 관리 및 치료를 위한 CDC의 지원으로 1,170만 명 이상이 항레트로바이러스 치료(ART)를 받고 있습니다.

노령인구의 증가는 세계 등온 핵산 증폭 기술 시장에 유망한 성장 기회를 제

노령 인구의 증가는 향후 몇 년 동안 세계 등온 핵산 증폭 기술 시장에 유망한 성장 기회를 제공하고 있습니다. 예를 들어, 유엔의 'World Population Prospects 2022'에 따르면 80세 이상 인구는 2022년 1억5700만 명에서 2050년 4억5900만 명으로 3배 증가할 것으로 예상됩니다.

COVID-19 영향 분석

COVID-19에 대한 분석에는 COVID 이전 시나리오, COVID 시나리오, COVID 이후 시나리오가 포함되며, 가격 역학(COVID 이전 시나리오와 비교한 팬데믹 중 및 팬데믹 이후 가격 변동 포함), 수요와 공급 스펙트럼(거래 제한, 봉쇄 및 후속 문제에 따른 수요와 공급의 변화), 정부의 노력(시장, 부문, 산업을 활성화하기 위한 정부 기관의 노력), 제조업체의 전략적 노력(제조업체가 COVID 문제를 완화하기 위해 취한 조치들을 다루고 있다) 등이 포함됩니다.

러시아-우크라이나 전쟁의 영향 분석

WHO는 러시아의 공격이 시작된 이후 의료 인프라에 대한 703건의 공격을 기록하고 있습니다. 또한, 러시아군이 이웃 국가인 우크라이나의 심장부까지 침공하면서 알루미늄, 구리, 철강, 플라스틱과 같은 주요 원자재 비용이 일반적인 인플레이션과는 별개로 백색가전의 추가 비용 상승을 초래하고 있습니다. 그러나 전쟁에도 불구하고 우크라이나는 환자에게 필요한 의료 서비스를 계속 제공하고 있습니다.

세계 불황의 영향 분석

과거 금융위기 때 의료기관이 해고를 고려했던 것처럼, 헬스케어 산업은 불황과 완전히 무관하지 않습니다. 하지만 이 산업은 그 특성상 다른 분야보다 더 잘 견뎌내고 있습니다. 하지만 인플레이션이 계속되는 가운데 경기침체 위기가 시장을 위협하고 있습니다.

세계 선진국의 고인플레이션은 지난 2년 동안 전반적인 비용 상승으로 나타나면서 경기 침체 지속에 대한 우려가 커지고 있습니다. 일반적인 구매력의 누적된 악화는 특히 성장 경제에 영향을 미칠 것으로 예상되며, 여러 가지 측면에서 유용하다고 여겨집니다.

인공지능의 영향 분석

인공지능은 향후 몇 년 동안 전 세계 등온 핵산 증폭 시장에 긍정적인 영향을 미칠 것으로 추정됩니다. 인공지능(AI)과 사물인터넷(IoT) 기술(AIoT)의 결합은 2세기 전 최초의 상업용 제빙기가 발명된 이후 등온 핵산 증폭에 가장 큰 파괴력을 발휘할 수 있습니다.

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

  • 영향요인
    • 성장 촉진요인
      • 보존을 목적으로 한 등온 핵산 증폭 기술에 대한 수요 증가
      • 시장 개발
    • 성장 억제요인
      • 재생품 이용 동향 상승
    • 기회
    • 정부 이니셔티브
    • 영향 분석

제5장 업계 분석

  • Porter's Five Forces 분석
  • 규제 분석
  • 가격 분석
  • 특허 분석
  • PEST 분석

제6장 COVID-19 분석

제7장 러시아·우크라이나 전쟁 분석

제8장 세계 불황 분석

제9장 인공 지능 영향 분석

제10장 제품 유형별

  • 기기
  • 시약

제11장 용도별

  • 감염증 진단
  • 혈액 스크리닝
  • 암 연구
  • 기타

제12장 기술별

  • 핵산 배열에 기반한 증폭(NASBA)
  • 싱글 프라이머 등온 증폭(SPIA)
  • 니킹 효소 증폭 반응(NEAR)
  • 헬리카제 의존 증폭(HDA)
  • 전사 매개 증폭(TMA)
  • 루프 매개 등온 증폭(LAMP)
  • 스트랜드 변위 증폭(SDA)
  • 기타

제13장 최종사용자별

  • 병원 및 진료소
  • 진단 센터
  • 연구소
  • 기타

제14장 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 남미
    • 브라질
    • 아르헨티나
    • 기타 남미
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카

제15장 경쟁 상황

  • 경쟁 시나리오
  • 시장 점유율 분석
  • M&A 분석

제16장 기업 개요

  • Thermo Fisher Scientific Inc.
    • 기업 개요
    • 제품 유형 포트폴리오와 설명
    • 재무 개요
    • 주요 발전
  • bioMerieux
  • Becton, Dickinson & Company
  • Lucigen
  • Qiagen
  • Quidel Corporation
  • Eiken Chemical Co. Ltd
  • Tecan Genomics Inc.
  • Meridian Bioscience
  • OptiGene Limited

제17장 부록

ksm 23.07.11

Market Overview

The Global Isothermal Nucleic Acid Amplification Technology Market reached USD 3.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 7.5 billion by 2030. the isothermal nucleic acid amplification technology market is expected to exhibit a CAGR of 11.1% during the forecast period 2023-2030.

Isothermal nucleic acid amplification is a technique that quickly and effectively collects nucleic acid series at a consistent temperature. Nucleic acid amplification technologies are employed in molecular biology and recombinant DNA approaches. These methods are employed as top practices in identifying and investigating a short number of nucleic acids.

Market Dynamics

The Growing Prevalence of Infectious Diseases Globally is Driving the Global Isothermal Nucleic Acid Amplification Technology Market in the Forecast Period.

The growing prevalence of infectious diseases globally is driving the global isothermal nucleic acid amplification technology (INAAT) market growth during the forecast period. For instance, the World Health Organization registered over 5,000 fresh monkeypox patients between October 24, 2022 to November 23, 2022. Moreover, at the end of 2021, over 11.7 million individuals were on Anti Retroviral Treatment (ART) outcome of the CDC's aid for HIV care and treatment via the U.S. President's Emergency Plan for AIDS Response.

The Growing Geriatric Population is Providing the Global Isothermal Nucleic Acid Amplification Technology Market With Prospective Growth Opportunities.

The growing geriatric population is presenting the global isothermal nucleic acid amplification market with prospective growth opportunities in the upcoming years. For instance, according to the World Population Prospects 2022, from the UN, the number of individuals aged 80 or above is anticipated to grow triple fold, from 157 million in 2022 to 459 million by 2050.

COVID-19 Impact Analysis

The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Russia-Ukraine War Impact Analysis

The war has negatively impacted the global isothermal nucleic acid amplification market to a slight extent as the WHO has recorded 703 attacks on health infrastructure since Russia's attack started. Moreover, as Russian armed forces progress deeper into the heart of neighboring Ukraine, costs of key raw materials such as aluminum, copper, steel and plastic, separated from general inflation, are currently threatening additional cost escalation for white goods commodities. However, despite the War, Ukraine continues to provide necessary health services to patients.

Global Recession Impact Analysis

The healthcare industry is not completely immune to recession, as healthcare institutions thought firings and employment during past financial downturns. That stated, the industry does cope finer than other sectors because of its essential nature. However, the danger of recession threatens the market as inflation persists increasing.

The elevated extent of tension about the persistent recession as the high inflation in developed countries worldwide has transpired in a general cost surge over the past two years. The cumulatively deteriorating general purchasing control is anticipated to affect growing economies particularly and is considered helpful in numerous ways.

Artificial Intelligence Impact Analysis

Artificial intelligence is estimated to have a positive impact on the global isothermal nucleic acid amplification market in the upcoming years. The combination of artificial intelligence (AI) and Internet of Things (IoT) technology (AIoT) may be the biggest disruption to the isothermal nucleic acid amplification since the invention of the first commercial ice-making machine two centuries ago.

Segment Analysis

The global isothermal nucleic acid amplification technology market is segmented based on product type, applications, technology and region.

The Loop-mediated Isothermal Amplification (LAMP) Technology Type Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period.

Loop-mediated Isothermal Amplification (LAMP) is estimated to hold 28.6% of the market share by 2030 owing to the increasing product introductions into the market. For instance, in March 2022, Thermo fisher scientific, an American supplier of scientific instrumentation, reagents and consumables and software services, introduced two new reverse transcription loop-mediated isothermal amplification-based developments that deliver a rapid and inexpensive technique for identifying viral pathogens.

Geographical Analysis

Europe is Estimated to Hold the Second-largest Share of the Global Isothermal Nucleic Acid Amplification Technology Market During the Forecast Period.

Owing to the increasing number of cancer dea?hs and growing efforts to fight against cancer Europe is estimated to hold around 25.9% of the global isothermal nucleic acid amplification market by 2030. For instance, according to the 2022 edition of Health at a Glance, cancer is the second greatest reason for death in the EU behind cardiovascular disorders.

Between 30-50% of cancer patients' deaths are avoidable and mortality can also be reduced through earlier detection and the condition of better punctual and effective therapies. Europe's Beating Cancer Plan strives to decrease the load of cancer and manage cancer-related imbalances between and within nations, with efforts to help, coordinate and complete the actions of Member States.

Competitive Landscape

The major global players in the market include: bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited and Thermo Fisher Scientific among others.

Why Purchase the Report?

  • To visualize the global isothermal nucleic acid amplification technology market segmentation based on product type, applications, technology, end user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of isothermal nucleic acid amplification technology market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Isothermal Nucleic Acid Amplification Technology Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 pages.

Target Audience 2023

  • Manufacturers / Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Applications
  • 3.3. Snippet by Technology
  • 3.4. Snippet by End User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Demand for Isothermal Nucleic Acid Amplification Technology for Storage Purposes
      • 4.1.1.2. Market Developments.
    • 4.1.2. Restraints
      • 4.1.2.1. The Growing Trend of Using Refurbished Equipment
    • 4.1.3. Opportunity
    • 4.1.4. Government Initiatives
    • 4.1.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. PEST Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario After COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Global Recession Analysis

9. Artificial Intelligence Impact Analysis

10. By Product Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.1.2. Market Attractiveness Index, By Product Type
  • 10.2. Instruments
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Reagents

11. By Applications

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 11.1.2. Market Attractiveness Index, By Applications
  • 11.2. Infectious Diseases Diagnostics*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Blood Screening
  • 11.4. Cancer Research
  • 11.5. Others

12. By Technology

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 12.1.2. Market Attractiveness Index, By Technology
  • 12.2. Nucleic Acid Sequence-based Amplification (NASBA)
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Single Primer Isothermal Amplification (SPIA)
  • 12.4. Nicking Enzyme Amplification Reaction (NEAR)
  • 12.5. Helicase-dependent Amplification (HDA)
  • 12.6. Transcription Mediated Amplification (TMA)
  • 12.7. Loop-mediated Isothermal Amplification (LAMP)
  • 12.8. Strand Displacement Amplification (SDA)
  • 12.9. Others

13. By End User

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.1.2. Market Attractiveness Index, By End User
  • 13.2. Hospitals and Clinics
    • 13.2.1. Introduction
    • 13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 13.3. Diagnostic Center
  • 13.4. Research Laboratories
  • 13.5. Others

14. By Region

  • 14.1. Introduction
    • 14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 14.1.2. Market Attractiveness Index, By Region
  • 14.2. North America
    • 14.2.1. Introduction
    • 14.2.2. Key Region-Specific Dynamics
    • 14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.2.7.1. The U.S.
      • 14.2.7.2. Canada
      • 14.2.7.3. Mexico
  • 14.3. Europe
    • 14.3.1. Introduction
    • 14.3.2. Key Region-Specific Dynamics
    • 14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.3.7.1. Germany
      • 14.3.7.2. The U.K.
      • 14.3.7.3. France
      • 14.3.7.4. Italy
      • 14.3.7.5. Spain
      • 14.3.7.6. Rest of Europe
  • 14.4. South America
    • 14.4.1. Introduction
    • 14.4.2. Key Region-Specific Dynamics
    • 14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.4.7.1. Brazil
      • 14.4.7.2. Argentina
      • 14.4.7.3. Rest of South America
  • 14.5. Asia-Pacific
    • 14.5.1. Introduction
    • 14.5.2. Key Region-Specific Dynamics
    • 14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.5.7.1. China
      • 14.5.7.2. India
      • 14.5.7.3. Japan
      • 14.5.7.4. Australia
      • 14.5.7.5. Rest of Asia-Pacific
  • 14.6. Middle East and Africa
    • 14.6.1. Introduction
    • 14.6.2. Key Region-Specific Dynamics
    • 14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

15. Competitive Landscape

  • 15.1. Competitive Scenario
  • 15.2. Market Share Analysis
  • 15.3. Mergers and Acquisitions Analysis

16. Company Profiles

  • 16.1. Thermo Fisher Scientific Inc.
    • 16.1.1. Company Overview
    • 16.1.2. Product Type Portfolio and Description
    • 16.1.3. Financial Overview
    • 16.1.4. Key Developments
  • 16.2. bioMerieux
  • 16.3. Becton, Dickinson & Company
  • 16.4. Lucigen
  • 16.5. Qiagen
  • 16.6. Quidel Corporation
  • 16.7. Eiken Chemical Co. Ltd
  • 16.8. Tecan Genomics Inc.
  • 16.9. Meridian Bioscience
  • 16.10. OptiGene Limited

LIST NOT EXHAUSTIVE

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제